Entourage Health Extends its Senior Secured Credit Facility Maturity Date
Entourage Health Corp. confirmed today it has signed an additional amendment to its senior secured credit facility entered into on March 29, 2019.
Entourage Health Reports Record First Quarter 2022 Financial Results
Entourage Health Corp. announced today its financial results for the three months ended March 31, 2022.
Entourage Health Announces Canadian Debut of The Boston Beer Company’s New Cannabis-Infused Iced Tea Beverages ‘TeaPot’
Entourage Health Corp. and The Boston Beer Company, Inc. are pleased to announce the Canadian debut of ‘TeaPot’, a new line of cannabis-infused iced tea beverages.
Entourage Health Reaffirms First Quarter 2022 Preliminary Record Revenues of $17.4 Million and Announces Financial Results Call to be held on May 31, 2022
Entourage Health Corp. announced today that it is scheduled to file its first quarter 2022 financial statements and management’s discussion and analysis after-market on Monday, May 30, 2022.
Entourage Health Enters into Voting Support Agreement and Announces Proposed Amendments to its 8.5% Unsecured Convertible Debentures
Entourage Health Corp. is pleased to announce that it has entered into voting support agreements with certain holders of the Company’s 8.5% unsecured convertible debentures due September 25, 2022…
Entourage Health to Present at the Canaccord Genuity 6th Annual Global Cannabis Virtual Conference on May 11th
Entourage Health Corp. announced today that George Scorsis, CEO and Executive Chair, and Vaani Maharaj, Chief Financial Officer, are scheduled to present at the Canaccord Genuity 6th Annual Global Cannabis Virtual Conference on Thursday, May 11th at 1 p.m. ET.
Entourage Reports Record Fiscal Year 2021 Financial Results with $55.2 Million in Total Revenue for a 56% Year-Over-Year Increase and Preliminary Q1 2022 Record Revenue of $17.4 Million
Entourage Health Corp. announced today its financial results for the fiscal year ended December 31, 2021.
Entourage Health Announces Issuance of Cease Trade Order
Entourage Health Corp. announced today that the Ontario Securities Commission (the “OSC”) has issued a Cease Trade Order (the “CTO”) as a result of the Company not filing its financial statements for the year ended December 31, 2021 and the related management’s discussion and analysis and CEO and CFO certifications (collectively, the “Annual Filings”) by May 2, 2022, being the date that such filings were due under applicable Canadian securities laws.
Entourage Health Partners with Pineapple Express to Provide Same-Day Medical Cannabis Delivery Service to its Starseed Medicinal Patients
Entourage Health Corp. announced today it has entered into an agreement with Fire & Flower Holdings Corp., a leading cannabis consumer retail and technology platform and its wholly owned delivery and logistics subsidiary, Pineapple Express Delivery Inc. to offer same-day and next-day delivery services to the Company’s Starseed Medicinal patients.
Entourage Health Reschedules Full-Year 2021 Earnings Release and Conference Call to Align with First Quarter 2022 Results
Entourage Health Corp. announced today it will defer its fourth quarter and full-year 2021 press release and conference call previously scheduled for May 3, 2022, to coincide with its projected first quarter 2022 financial results, expected on or before May 31, 2022.
Entourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $15 Million in Funding Availability
Entourage Health Corp. is pleased to announce it has amended and upsized its existing credit facility with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada, adding an additional $15 million in funding availability.
Entourage Updates Timing of Fiscal Year 2021 Financial Results Call to May 3, 2022
Entourage Health Corp. announced today that it will file its fourth quarter and full-year 2021 financial statements and management’s discussion and analysis after-market on Monday May 2, 2022.
Entourage Health Extends Senior Secured Credit Facility Maturity Date
Entourage Health Corp. confirmed today it has signed an additional amendment to its senior secured credit facility entered into on March 29, 2019.
Entourage Health Launches ‘Joints for Justice’ Retail Campaign to Raise Funds and Awareness in Support of Cannabis Amnesty
Pre-roll products available at Ontario retail stores via the Company’s craft brand Royal City Cannabis Co., with $1 of every pre-roll sold going to the advancement of Cannabis Amnesty’s initiatives
Entourage Appoints Finance Executive Vaani Maharaj as New Chief Financial Officer and Updates Timing of Q4 and Full-Year 2021 Financials to April 26
Entourage Health Corp. is pleased to announce the appointment of Vaani Maharaj, a seasoned financial executive with broad experience in corporate finance, healthcare and consumer-packaged goods (CPG).
Entourage Health Debuts New 2022 Color Cannabis Branding Campaign and Celebrates All-Female-Led Marketing and Promotions Team
On this International Women’s Day, the Company proudly spotlights its all-female trade and brand marketing team behind the 2022 launch of “Just add Color” anchored in colour theory
Entourage Health Announces Preliminary Fiscal Year 2021 Record Revenue of $54.8 Million with Q4 and Full-Year 2021 Financials to be filed by April 1, 2022
Company also provides a corporate update and confirms George Scorsis as permanent CEO
Entourage Health Launches New Premium Color Cannabis Products
Includes Ontario launch of specialty concentrate product “Pedro’s Sweet Sativa Live Sugar”; debut of high-THC, rare cultivar “Space Cake”; and “Black Sugar Rose 10-pack Pre-rolls”
Entourage Health Posts New Year 2022 Shareholder Newsletter
Entourage Health issued an open letter to shareholders today to provide a recap of its corporate and operational achievements attained over the past year, and an overview of what is expected in 2022.
Entourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $20 Million in Non-Dilutive Financing
Funding to enhance cultivation growth with tissue culture and market new genetics with premium products via Color Cannabis, Royal City Cannabis, Saturday Cannabis and Starseed Medicinal